Fagron is proud to welcome the pharmaceutical company AnazaoHealth Corporation into the Fagron Family. AnazaoHealth is a leading sterile specialty pharma facility in the United States specialized in nuclear, pain and intrathecal customized medication. This highly professional company is based in Tampa, Florida and Las Vegas, Nevada and became part of the Fagron Group in May 2015.
The nuclear customized medication that AnazaoHealth carries out is a specialty area of pharmacy dedicated to radioactive materials for use in nuclear medicine procedures, including cancer treatments and diagnostics. The benefits of AnazoaHealth’s specialism for patients are numerous:
- Customized treatment
- Isolated tumor treatment without impacting healthy tissue
- No surgery needed
- Less side effects, such as infections or incontinence
- A four-hour policlinic treatment versus weekly hospitalized radiation treatment
The products of AnazaoHealth are serviced to hospitals and specialized surgery clinics.
With this acquisition Fagron further strengthens its leading market position in the United States and underlines its continuous focus on customized medication to meet the growing demand of hospitals that want to outsource nuclear, sterile and aseptic activities to one of Fagron's state-of-the-art specialty pharma facilities.